Skip to main content
. 2013 Jan 26;14:25. doi: 10.1186/1471-2369-14-25

Table 2.

Outcome Ascertainment for INSIGHT

  Follow up time since initial onset (months)
4 8 12 24 36 48 60
Clinical
  
  
  
  
  
  
  
Remission: Urine protein/creatinine < 0.2 or Albustik negative or trace for 3 consecutive days
 x
 x
 x
 x
 x
 x
 x
Relapse: After remission, an increase in the first morning urine protein/creatinine ≥2 for 3 of 5 consecutive days
 x
 x
 x
 x
 x
 x
 x
Frequently relapsing NS: 4 or more relapses within 1 year OR 2 or more relapses within 6 months
  
  
 x
 x
 x
 x
 x
Steroid dependant NS: Relapse during steroid taper or within 14 days of steroid discontinuation
 x
 x
 x
 x
 x
 x
 x
Steroid resistant: Inability to induce remission within 28 days of steroid therapy
 x
 x
 x
 x
 x
  
  
Laboratory
              
Urine protein/creatinine: Abnormal if > 250 mg/mmol
 x
 x
 x
 x
 x
 x
 x
Urine albumin/creatinine: Abnormal if > 30 mg/mol
 x
 x
 x
 x
 x
 x
 x
Creatinine based eGFR: eGFR by modified Schwartz (ml/min/1.73 m2) = k x height/serum creatinine
 x
 x
 x
 x
 x
 x
 x
CKD/ESRD: eGFR < 60 ml/min/1.73 m2 (or dialysis)       Anytime